| Stage | QSR | % of rev | MCD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.5B | 100.00% | $7.1B | 100.00% | MCD ×2.82 |
| Gross profit | $1.4B | 54.64% | $4.3B | 60.30% | MCD +5.7pp |
| Operating income | $716M | 28.41% | $3.3B | 47.02% | MCD +18.6pp |
| Pre-tax income | $592M | 23.49% | $2.9B | 41.36% | MCD +17.9pp |
| Net income | $665M | 26.39% | $2.4B | 33.27% | MCD +6.9pp |
| Stage | QSR | MCD | Gap · A − B |
|---|---|---|---|
| Revenue | $2.5B100.00% | $7.1B100.00% | MCD ×2.82 |
| Gross profit | 54.64%$1.4B | 60.30%$4.3B | MCD +5.7pp |
| Operating income | 28.41%$716M | 47.02%$3.3B | MCD +18.6pp |
| Pre-tax income | 23.49%$592M | 41.36%$2.9B | MCD +17.9pp |
| Net income |
| 26.39%$665M |
| 33.27%$2.4B |
| MCD +6.9pp |
No shared counterparties.